Главная
Рынки
Графики и идеи
Алготрейдинг
Новости
Store
Брокеры
Скачать
Экономический календарь
Торговые сигналы
Вебтерминал
Нажмите
/
для поиска: @user, $symbol, ...
Поиск
Вход
Создать аккаунт
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LUNG
#3421
Pulmonx Corporation Common Stock
1.5
8
+0.64%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
Годовой диапазон
Дневное изменение
+0.64%
Месячное изменение
-9.71%
6-месячное изменение
-15.05%
Годовое изменение
-81.28%
Предыдущее закрытие
1.5
7
Open
1.5
8
Bid
Ask
Low
1.5
8
High
1.5
8
Объем
26
Рынки
Рынок акций США
Здравоохранение
LUNG
Open full chart
Financials
Overview
Отчетность
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
39.49 M
39.8 M
40.26 M
40.75 M
41.25 M
—
Valuation ratios
Enterprise value
301.28 M
236.49 M
233.57 M
67.18 M
27.4 M
564.65 M
Price to earnings ratio
-5.64
-4.72
-4.67
-1.81
-1.15
-12.35
Price to sales ratio
4.05
3.17
3.03
1.14
0.71
8.04
Price to cash flow ratio
9.65
8.43
8.07
3.31
2.03
21.84
Price to book ratio
0.76
3.09
0.74
0.31
0.22
4.37
Enterprise value to EBITDA ratio
-5.31
-4.18
-4.13
-1.21
-0.49
-10.01
Profitability ratios
Return on assets %
0.08
0.08
0.1
0.1
0.1
0.38
Return on equity %
0.15
0.15
0.19
0.22
0.23
0.79
Return on invested capital %
61.58
67.77
87.64
105.15
125.41
385.97
Gross margin %
73.7
74.02
72.51
72.11
74.65
293.29
Operating margin %
69.3
56.46
64.62
62.05
66.94
250.06
EBITDA margin %
-67.92
-55.34
-62.92
-60.04
-64.52
-242.82
Net margin %
69.38
55.44
64.11
63.59
64.91
248.05
Liquidity ratios
Quick ratio
6.77
4.88
4.29
4.63
4.15
17.96
Current ratio
7.7
5.58
4.97
5.35
4.86
20.75
Inventory turnover
0.32
0.36
0.37
0.4
0.34
1.47
Asset turnover
0.12
0.14
0.14
0.16
0.15
0.6
Solvency ratios
Debt to assets ratio
0.22
0.23
0.25
0.25
0.27
1
Debt to equity ratio
0.4
0.43
0.48
0.54
0.62
2.07
Long term debt to total assets ratio
0.22
0.21
0.19
0.25
0.27
0.92
Long term debt to total equity ratio
0.4
0.4
0.38
0.54
0.62
1.93
Per share metrics
Operating cash flow per share
0.18
0.17
0.33
0.1
0.2
0.8
EBIT per share
-0.36
-0.34
-0.36
-0.37
-0.35
-1.43
EBITDA per share
-0.35
-0.34
-0.35
-0.35
-0.34
-1.38
Total debt per share
0.95
0.95
0.93
0.92
0.91
3.71
Cash per share
1.61
1.81
1.87
1.87
1.87
7.42
Net current asset value per share
3.59
3.48
3.1
2.97
2.72
12.27
Tangible book value per share
2.33
2.13
1.89
1.65
1.41
7.08
Working capital per share
3.12
2.86
2.48
2.41
2.16
9.91
Book value per share
2.39
2.19
1.94
1.71
1.47
7.31
Новости
Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates
Privia Health (PRVA) Q4 Earnings and Revenues Beat Estimates
Pulmonx首席执行官French出售价值1.38万美元的LUNG股票
Stifel在Pulmonx第三季度业绩后重申"买入"评级
Pulmonx stock rating reiterated at Buy by Stifel after 3Q results
PulmonxQ3每股收益及营收超出预期
Pulmonx earnings beat by $0.08, revenue topped estimates
Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates
Cisco, Flutter, Manulife and more set to report earnings Wednesday
American Well Corporation (AMWL) Reports Q3 Loss, Beats Revenue Estimates
Canaccord Genuity重申Pulmonx股票买入评级,公司领导层变动
Canaccord Genuity reiterates Buy rating on Pulmonx stock amid leadership changes